RS
Highly rated in
11
conditions
Highly rated in
11
conditions
Check Dr. Raphael Schiffmann's experience treating your condition:
About Dr. Raphael Schiffmann

Raphael Schiffmann is a Neurologist and a Neurosurgery expert in Dallas, Texas. Schiffmann has been practicing medicine for over 43 years and is highly rated in 11 conditions, according to our data. His top areas of expertise are Fabry Disease, Gaucher Disease Type 3, Leukodystrophy, and Gaucher Disease. He is licensed to treat patients in Texas. Schiffmann is currently accepting new patients.

His clinical research consists of co-authoring 150 peer reviewed articles and participating in 11 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Raphael Schiffmann it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Raphael Schiffmann accepts the following insurance:

  •  Blue Cross Blue Shield
  •  Ambetter
  •  Superior HealthPlan
  •  Friday Health
Locations
3500 Gaston Ave, Dallas, TX 75246
Other Locations
6080 N Central Expy, Ste 100, Dallas, TX 75206
Background & Education
Graduate Institution
Other, 1980
Specialties
Neurology
Neurosurgery
Licenses
Neurology with Special Qualifications in Neurology in TX
Hospital Affiliations
Baylor University Medical Center - Dallas
Languages Spoken
English
French
Spanish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


11 Clinical Trials

A Randomized, Double Blind, Active Control Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function in Patients With Fabry Disease Previously Treated With Agalsidase Beta
An Open-Label Clinical Trial of Replagal® Enzyme Replacement Therapy in Children With Fabry Disease Who Are Naive to Enzyme Replacement Therapy
An Open-label Treatment Protocol to Evaluate the Safety of Replagal Treatment in Patients With Fabry Disease.
The Etiology, Pathogenesis, and Natural History of the Leukodystrophies
The Natural History of Mucolipidosis Type IV
A Treatment Trial of Triheptanoin in Patients With Adult Polyglucosan Body Disease - A Randomized Controlled Study
The Effect of Velaglucerase Alfa (Vpriv) on Skeletal Development in Pediatric Gaucher Disease
Expanded Screening for Fabry Trait
Androgenetic Alopecia in Fabry Disease
View 10 Less Clinical Trials -

149 Total Publications

Dysregulated DNA methylation in the pathogenesis of Fabry disease.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors